View drug registration information details.
Items | Registration information |
ID | 1735 |
No | 1735 |
Brand Name | LUCIFUTIB |
Ingredients | FUTIBATINIB 4 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 35'S/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED, UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC INTRAHEPATIC CHOLANGIOCARCINOMA HARBORING FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE FUSION OR OTHER REAARANGEMENTS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE TABLETS, LETTER LUS ON ONE SIDE AND PLAIN ON THE OTHER |
Note | |
License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 09 L 1212/24 |
FDD Registration Date | 02-OCT-2024 |
Expiry Date | 01-OCT-2029 |
Back to drug list
|